In both tumors, two major clones were identified among the tumor cells, namely one clone with Myc or Mycn amplification, respectively, with co-occurrence of gains associated with complex genomic rearrangements, and a second clone with Myc or Mycn amplification but no gain associated with complex genomic rearrangements (Supplementary Figure 3). This evidence concerns the gene MYCN and neoplasm.